Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Taurolidine Lock for Prevention of Central-Line Associated Bloodstream Infections in Neonates: A Triple-blind Randomized Controlled Trial

NCT07585188 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT07585188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07585188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Taurolidine Lock for Prevention of Central-Line Associated Bloodstream Infections in Neonates: A Triple-blind Randomized Controlled Trial
Lead sponsor
University of Turin, Italy
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
October 31, 2029
Enrollment
576 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clabsi - central line associated bloodstream infection, crbsi - catheter related bloodstream infection, neonatal sepsis, late-onset